SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients

Kazem Vatankhah Yazdi,1 Seyed Mehdi Kalantar,1 Massoud Houshmand,2,3 Masoud Rahmanian,4 Masoud Reza Manaviat,5 Mohammad Reza Jahani,6 Behnam Kamalidehghan,2,7 Amir Almasi-Hashiani8 1Department of Genetic, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd, Iran; 2Department of...

Full description

Bibliographic Details
Main Authors:	Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-03-01
Series:	Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:	type 2 diabetes mellitus (t2dm) iranian populations the tetra amplification refractory mutation system (arms) the genome-wide association studies (gwas) pharmacogenetics and pharmacogenomic
Online Access:	https://www.dovepress.com/slc30a8-cdkal1-tcf7l2-kcnq1-and-igf2bp2-are-associated-with-type-2-dia-peer-reviewed-article-DMSO

Similar Items

Allele Drop Out Conferred by a Frequent CYP2D6 Genetic Variation For Commonly Used CYP2D6*3 Genotyping Assays
by: Giada Scantamburlo, et al.
Published: (2017-10-01)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

An Interdisciplinary Experience focused on Pharmacogenetics: Engaging pharmacy and physician assistant students in conversations about antiplatelet therapy with respect to CYP2C19 genotype
by: Diane M Calinski, et al.
Published: (2016-02-01)

Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus
by: Hector E. Sanchez-Ibarra, et al.
Published: (2018-04-01)

Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
by: Kisor DF, et al.
Published: (2021-05-01)

Parents' and adolescents' access to and impressions of pharmacogenetic results viewed within a patient portal
by: Reardon, Meghann
Published: (2016)

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population
by: Nattachet Plengvidhya, et al.
Published: (2018-06-01)

Pharmacogenomics and Pharmacogenetics: In Silico Prediction of Drug Effects in Treatments for Novel Coronavirus SARS-CoV2 Disease
by: Cafiero C, et al.
Published: (2020-10-01)

by: Kathleen B Orrico
Published: (2019-12-01)

The Effects of Personal Pharmacogenetic Testing on the Effects of Pharmacy Student Perceptions of Knowledge and Attitudes Towards Precision Medicine
by: Dalga D Surofchy, PharmD (c), et al.
Published: (2017-01-01)

What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?
by: Adam Jameson, et al.
Published: (2021-09-01)

Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes
by: Tanja Dujic, et al.
Published: (2019-05-01)

Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection
by: Alfredo B. Cuéllar-Barboza, et al.
Published: (2020-07-01)

Pharmacogenomics of neuropathic pain
by: Vandana Sharma
Published: (2017-01-01)

Personalized medicines – are pharmacists ready for the challenge?
by: Kennedy MJ
Published: (2018-09-01)

Tailor-made medicine: Is it practical?
by: Poornima Govindraju, et al.
Published: (2016-01-01)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
by: Eljilany I, et al.
Published: (2021-08-01)

Variation in CYP2A6 Activity and Personalized Medicine
by: Julie-Anne Tanner, et al.
Published: (2017-12-01)

Pathway-targeted pharmacogenomics of CYP1A2 in human liver
by: Kathrin eKlein, et al.
Published: (2010-11-01)

Introducing Pharmacogenetics and Personalized Medicine via a Weblog
by: Kaitlin Bova, et al.
Published: (2014-01-01)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
by: Rattanacheeworn P, et al.
Published: (2020-10-01)

KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment
by: Jingwen Song, et al.
Published: (2017-06-01)

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines
by: Heshu Abdullah-Koolmees, et al.
Published: (2021-01-01)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
by: Claudia Maria Hattinger, et al.
Published: (2020-06-01)

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study
by: Angela Roco, et al.
Published: (2020-04-01)

Precision Medicine: Emerging Trends in Cancer Therapy
by: Rahul Badwaik
Published: (2019-10-01)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
by: Camilla eStephens, et al.
Published: (2012-11-01)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
by: Darcy Adin, et al.
Published: (2020-03-01)

Clinical Application and Evaluation of Pharmacogenomics in Tumor Chemotherapy
by: Jifeng Feng
Published: (2014-03-01)

Web Resources for Pharmacogenomics
by: Guoqing Zhang, et al.
Published: (2015-02-01)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01)

Personalized medicine: A step forward in dental treatment
by: Surbhi, et al.
Published: (2015-01-01)

Curriculum in Pharmacogenetics and Pharmacogenomics in the Colleges and Schools of Pharmacy in the United States
by: Adams, Laura, et al.
Published: (2009)

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China
by: Chengxian Guo, et al.
Published: (2021-07-01)

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
by: Kristi Krebs, et al.
Published: (2019-08-01)

Implication of genetic variants near <it>SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2</it>, <it>KCNQ1</it>, and <it>WFS1 </it>in Type 2 Diabetes in a Chinese population
by: Zhou Xianghai, et al.
Published: (2010-05-01)

Perspectives of pharmacogenetics approach to personalized tamoxifen therapy
by: M I Savelyeva, et al.
Published: (2017-06-01)